Boosted by Apple, Wall Street parties like it's 19,999

Go back to Boosted by Apple, Wall Street parties like it's 19,999

Jefferies Cuts Price Target on Regeneron (REGN) Following District Court Ruling

January 6, 2017 9:28 AM EST

Jefferies maintained a Hold rating on Regeneron Pharma (NASDAQ: REGN), and cut the price target to $349.00 (from $394.00), following a decision by the District Court of Delaware. Judge Sue Robinson at the District Court of Delaware ruled in favor of Amgen (NASDAQ:... More